Shares of Moderna plunge as the company cuts its 2021 forecast for Covid vaccine sales. megtirrell has the details.
shares fell by more than 16% on Thursday after it cut its Covid-19 vaccine sales forecast for the year and missed earnings and revenue expectations for the third quarter.
By comparison, Pfizer has said it expects Covid vaccine sales of $36 billion this year and $29 billion in 2022. He said the company is working to ensure the vaccine is available in low-income countries by providing approximately 10% of its 2021 volume to them, and "significantly more" volume next year.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumbleModerna Inc on Thursday cut its 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, as it struggles to ramp up production of its two-dose inoculation, sending its shares down 11% in premarket trading.
Les mer »
Moderna Cuts Covid-19 Vaccine Sales Forecast for 2021Moderna's third-quarter earnings fell short of estimates as the pharmaceutical company lowered its sales outlook for the full year and said that some planned Covid-19 vaccine deliveries will slip into early 2022
Les mer »
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 blnPfizer Inc on Tuesday said it expected this year to sell $36 billion of the COVID-19 vaccine it developed with German partner BioNTech and forecast another $29 billion in sales in 2022, topping analyst estimates for both years.
Les mer »
Diwali 2021: India celebrates festival of lights under shadow of Covid-19Marked by feasts and fireworks, Diwali is one of the most important festivals in India.
Les mer »
As China faces its most widespread Covid outbreak since Wuhan, officials double down on zero CovidChina is scrambling to contain its most widespread Covid-19 outbreak since the first wave of infections that began in Wuhan in 2019.
Les mer »
Pfizer Raises Covid-19 Vaccine Forecast as Sales More Than DoublePfizer raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7% boost from previous guidance
Les mer »